Astellas Pharma Inc is a specialty international pharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ALPMY is expected to report earnings to fall 28.50% to 20 cents per share on February 09
Q4'25
Est.
$0.21
Q3'25
Beat
by $0.12
Q2'25
Beat
by $0.12
Q1'25
Beat
by $41.06
Q4'24
Missed
by $0.41
The last earnings report on October 30 showed earnings per share of 28 cents, beating the estimate of 17 cents. With 65.45K shares outstanding, the current market capitalization sits at 21.70B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ALPMY showed earnings on October 30, 2025. You can read more about the earnings report here.